SLC2A1 and cancer: In addition to inhibiting MCTs, both phloretin and pCMBS target the glucose transporter GLUT, but this should not compromise the analysis of astrocytes, neurons, cancer cells, fibroblasts, cell lines in general and other cells that maintain resting intracellular glucose at levels > 300 μM [34], [37], [40].